Top

Published in:

01-09-2009

Percutaneous renal tumor ablation

Authors: Mansi Saksena, D. Gervais

Published in: Abdominal Radiology | Issue 5/2009

Abstract

Recent increase in utilization of cross-sectional imaging has resulted in increased detection of early renal cancer. Percutaneous ablation is a relatively new technique for the treatment of renal cancer. This article provides an overview of clinical indications, technique, and results of percutaneous ablation of renal cancer.

Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477–2490PubMedCrossRef

Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer. J Clin 2008;58:71–96PubMedCrossRef

Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323–331PubMed

Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000;217:657–664PubMed

Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002;60:40–49PubMedCrossRef

Rupp CC, Hoffmann NE, Schmidlin FR, et al. Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation. Cryobiology 2002;45:167–182PubMedCrossRef

Chosy SG, Nakada SY, Lee FT Jr, Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 1998;159:1370–1374PubMedCrossRef

Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol 2005;15:960–967PubMedCrossRef

Gervais DA, Arellano RS, Mueller P. Percutaneous ablation of kidney tumors in nonsurgical candidates. Oncology (Williston Park) 2005;19:6–11

10.

Chiou YY, Hwang JI, Chou YH, Wang JH, Chiang JH, Chang CY. Percutaneous radiofrequency ablation of renal cell carcinoma. J Chin Med Assoc 2005;68:221–225PubMedCrossRef

11.

Ahrar K, Matin S, Wood CG et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol 2005;16:679–688PubMed

12.

Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003;180:1509–1513PubMed

13.

Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003;180:1503–1508PubMed

14.

Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003;61:26–33PubMedCrossRef

15.

Ogan K, Jacomides L, Dolmatch BL, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 2002;60:954–958PubMedCrossRef

16.

Zagoria RJ, Hawkins AD, Clark PE et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004;183:201–207PubMed

17.

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64–71PubMed

18.

Rouviere O, Badet L, Murat FJ et al. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Cardiovasc Intervent Radiol 2008;31:595–603PubMedCrossRef

19.

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003;226:417–424PubMedCrossRef

20.

Krehbiel K, Ahmad A, Leyendecker J, Zagoria R (2008) Thermal ablation: update and technique at a high-volume institution. Abdom Imaging 33(6):695–706

21.

Boss A, Rempp H, Martirosian P, et al. (2008) Wide-bore 1.5 tesla MR imagers for guidance and monitoring of radiofrequency ablation of renal cell carcinoma: initial experience on feasibility. Eur Radiol 18(7):1449–1455

22.

Boss A, Clasen S, Kuczyk M et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 2005;40:583–590PubMedCrossRef

23.

Littrup PJ, Ahmed A, Aoun HD, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol 2007;18:383–392PubMedCrossRef

24.

Silverman SG, Tuncali K, vanSonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy–initial experience in 23 patients. Radiology 2005;236:716–724PubMedCrossRef

25.

Shingleton WB, Sewell PE Jr. Cryoablation of renal tumours in patients with solitary kidneys. BJU Int 2003;92:237–239PubMedCrossRef

26.

Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ. (2007) CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 27:325–339 (discussion 339–340).

27.

Lokken RP, Gervais DA, Arellano RS et al. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol 2007;189:845–848PubMedCrossRef

28.

Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 2004;172:874–877PubMedCrossRef

29.

Allaf ME, Varkarakis IM, Bhayani SB, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology 2005;237:366–370PubMedCrossRef

30.

Wah TM, Arellano RS, Gervais DA, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005;237:1097–1102PubMedCrossRef

31.

Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005;185:72–80PubMed

32.

Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167:10–15PubMedCrossRef

33.

Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am J Roentgenol 2003;180:1055–1061PubMed

34.

Veltri A, De Fazio G, Malfitana V, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol 2004;14:2303–2310PubMedCrossRef

35.

Park BK, Kim CK, Lee HM (2008) Image-guided radiofrequency ablation of bosniak category III or IV cystic renal tumors: initial clinical experience. Eur Radiol

36.

Shingleton WB, Sewell PE Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 2001;165:773–776PubMedCrossRef

37.

Mourikis D, Chatziioannou A, Antoniou A, Kehagias D, Gikas D, Vlahos L. Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur J Radiol 1999;32:153–159PubMedCrossRef

38.

Wood BJ, Grippo J, Pavlovich CP. Percutaneous radio frequency ablation for hematuria. J Urol 2001;166:2303–2304PubMedCrossRef

39.

Neeman Z, Sarin S, Coleman J, Fojo T, Wood BJ. Radiofrequency ablation for tumor-related massive hematuria. J Vasc Interv Radiol 2005;16:417–421PubMed

40.

Zagoria RJ. Imaging-guided radiofrequency ablation of renal masses. Radiographics 2004;24(Suppl 1):S59–S71PubMedCrossRef

Title: Percutaneous renal tumor ablation
Authors: Mansi Saksena
D. Gervais
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Abdominal Radiology / Issue 5/2009
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-008-9478-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2009

Torsion of the spermatic cord: the main gray-scale and doppler sonographic signs

CT appearance of Epstein-Barr virus-associated gastric carcinoma

Ablation of adrenal neoplasms

Radiologic findings following Y90 radioembolization for primary liver malignancies

Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response

Extrapancreatic neural plexus invasion by pancreatic carcinoma: characteristics on magnetic resonance imaging

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials